BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7250192)

  • 1. Kainic acid lesions dissociate [3H] spiperone and [3H]cis-flupenthixol binding sites in rat striatum.
    Cross AJ; Waddington JL
    Eur J Pharmacol; 1981 May; 71(2-3):327-32. PubMed ID: 7250192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of 3H-cis-flupenthixol binding to calf brain membranes.
    Cross AJ; Owen F
    Eur J Pharmacol; 1980 Aug; 65(4):341-7. PubMed ID: 7408943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irreversible interaction of beta-haloalkylamine derivatives with dopamine D1 and D2 receptors.
    Cross AJ; Waddington JL; Ross ST
    Life Sci; 1983 Jun; 32(24):2733-40. PubMed ID: 6222234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kainate lesion dissociates striatal dopamine receptor radioligand binding sites.
    Leff S; Adams L; Hyttel J; Creese I
    Eur J Pharmacol; 1981 Mar; 70(1):71-5. PubMed ID: 7215442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication.
    Van der Werf JF; Van het Schip F; Sebens JB; Korf J
    Eur J Pharmacol; 1984 Jul; 102(3-4):387-99. PubMed ID: 6436037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of 3H-cis-flupenthixol binding in rat striatum.
    Murrin LC
    Life Sci; 1983 Nov; 33(22):2179-86. PubMed ID: 6645796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
    Quik M; Emson PC; Joyce E
    Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific [3H]piflutixol binding to CHAPS-solubilised rat striatal preparations involves dopamine D-2 but not D-1 binding sites.
    Kilpatrick GJ; Jenner P; Marsden CD
    J Neurochem; 1986 Feb; 46(2):413-21. PubMed ID: 3941314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible blockade of striatal dopamine receptors in vivo by a derivative of alpha-flupenthixol.
    Schuster DI; Holden WL; Narula AP; Murphy RB
    Eur J Pharmacol; 1982 Feb; 77(4):313-6. PubMed ID: 7060641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evidence that 3H-cis(Z)flupenthixol binds to the adenylate cyclase-associated dopamine receptor (D-1) in rat corpus striatum.
    Hyttel J
    Psychopharmacology (Berl); 1980 Jan; 67(1):107-9. PubMed ID: 6768074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
    Hall MD; Jenner P; Kelly E; Marsden CD
    Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake.
    Murugaiah K; Fleminger S; Theodorou A; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Sep; 32(17):2495-9. PubMed ID: 6684429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of neuroleptic receptor sites in mouse brain by autoradiography.
    Höllt V; Schubert P
    Brain Res; 1978 Jul; 151(1):149-53. PubMed ID: 679000
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kainic acid lesions of striatum and decortication reduce specific [3H]sulpiride binding in rats, so D-2 receptors exist post-synaptically on corticostriate afferents and striatal neurons.
    Theodorou A; Reavill C; Jenner P; Marsden CD
    J Pharm Pharmacol; 1981 Jul; 33(7):439-44. PubMed ID: 6115030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]spiperone binds selectively to rat striatal D2 dopamine receptors in vivo: a kinetic and pharmacological analysis.
    Leslie CA; Bennett JP
    Brain Res; 1987 Mar; 407(2):253-62. PubMed ID: 2952221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postsynaptic location of acrylamide-induced modulation of striatal 3H-spiroperidol binding.
    Hong JS; Tilson HA; Agrawal AK; Karoum F; Bondy SC
    Neurotoxicology; 1982 Jul; 3(1):108-12. PubMed ID: 6890181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.